Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Adriana Iriarte"'
Autor:
Raquel Torres-Iglesias, José María Mora-Luján, Adriana Iriarte, Pau Cerdà, Esther Alba, Miguel Ángel Sánchez-Corral, Ana Berrozpe, Francesc Cruellas, Enric Gamundí, Jesús Ribas, Jose Castellote, Antoni Riera-Mestre
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundChronic bleeding due to gastrointestinal (GI) involvement in patients with hemorrhagic hereditary telangiectasia (HHT) can provoke severe anemia with high red blood cells (RBC) transfusion requirements. However, the evidence about how to de
Externí odkaz:
https://doaj.org/article/eaa7b1d405214628a7019fa81935a3f1
Autor:
Bernat Villanueva, Adriana Iriarte, Raquel Torres-Iglesias, Miriam Muñoz Bolaño, Pau Cerdà, Antoni Riera-Mestre
Publikováno v:
Medicina, Vol 59, Iss 9, p 1533 (2023)
Herein, we present the first described hereditary hemorrhagic telangiectasia (HHT) patient treated with aflibercept for severe GI involvement after tachyphylaxis to bevacizumab, with promising results. HHT is a rare genetic disease characterized by s
Externí odkaz:
https://doaj.org/article/85d9c57f04a14baf8f7755c4dc77113e
Autor:
Manuel Rubio-Rivas, Mar Ronda, Ariadna Padulles, Francesca Mitjavila, Antoni Riera-Mestre, Carlos García-Forero, Adriana Iriarte, Jose M. Mora, Nuria Padulles, Monica Gonzalez, Xavier Solanich, Merce Gasa, Guillermo Suarez-Cuartin, Joan Sabater, Xose L. Perez-Fernandez, Eugenia Santacana, Elisabet Leiva, Albert Ariza-Sole, Paolo D. Dallaglio, Maria Quero, Antonio Soriano, Alberto Pasqualetto, Maylin Koo, Virginia Esteve, Arnau Antoli, Rafael Moreno-Gonzalez, Sergi Yun, Pau Cerda, Mariona Llaberia, Francesc Formiga, Marta Fanlo, Abelardo Montero, David Chivite, Olga Capdevila, Ferran Bolao, Xavier Pinto, Josep Llop, Antoni Sabate, Jordi Guardiola, Josep M. Cruzado, Josep Comin-Colet, Salud Santos, Ramon Jodar, Xavier Corbella
Publikováno v:
International Journal of Infectious Diseases, Vol 101, Iss , Pp 290-297 (2020)
Objectives: To assess the characteristics and risk factors for mortality in patients with severe coronavirus disease-2019 (COVID-19) treated with tocilizumab (TCZ), alone or in combination with corticosteroids (CS). Methods: From March 17 to April 7,
Externí odkaz:
https://doaj.org/article/cab2b18f27f244579286c1729f9adeb0
Autor:
Rosario Sánchez-Martínez, Adriana Iriarte, José María Mora-Luján, José Luis Patier, Daniel López-Wolf, Ana Ojeda, Miguel Angel Torralba, María Coloma Juyol, Ricardo Gil, Sol Añón, Joel Salazar-Mendiguchía, Antoni Riera-Mestre, for the RiHHTa Investigators of the Rare Diseases Working Group from the Spanish Society of Internal Medicine
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-8 (2020)
Abstract Background Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular disease with autosomal dominant inheritance. Disease-causing variants in endoglin (ENG) and activin A receptor type II-like 1 (ACVRL1) genes are detected in more than
Externí odkaz:
https://doaj.org/article/b1d76d1112d04ce795aed657b802468f
Autor:
Xavier Solanich, Arnau Antolí, Gemma Rocamora-Blanch, Núria Padullés, Marta Fanlo-Maresma, Adriana Iriarte, Francesca Mitjavila, Olga Capdevila, Antoni Riera-Mestre, Jordi Bas, Vanesa Vicens-Zygmunt, Jordi Niubó, Nahum Calvo, Santiago Bolivar, Raúl Rigo-Bonnin, Anna Mensa-Vilaró, Laura Arregui, Cristian Tebe, Sebastià Videla, Pilar Hereu, Xavier Corbella
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients.Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate th
Externí odkaz:
https://doaj.org/article/938b2936f61e4dbd962540ba0a0b4e64
Autor:
Pau Cerdà, Jesus Ribas, Adriana Iriarte, José María Mora-Luján, Raquel Torres, Belén Del Río, Héctor Ignacio Jofre, Yolanda Ruiz, Marta Huguet, Mari Paz Fuset, Sergio Martínez-Yélamos, Salud Santos, Núria Llecha, Xavier Corbella, Antoni Riera-Mestre
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243533 (2020)
BackgroundA higher incidence of thrombotic events, mainly pulmonary embolism (PE), has been reported in hospitalized patients with COVID-19. The main objective was to assess clinical and laboratory differences in hospitalized COVID-19 patients accord
Externí odkaz:
https://doaj.org/article/09cdf1aab65c4ed0ace3a3079083b9dd
Autor:
Adriana Iriarte, Agnes Figueras, Pau Cerdà, José María Mora, Anna Jucglà, Rosa Penín, Francesc Viñals, Antoni Riera-Mestre
Publikováno v:
Cells, Vol 8, Iss 9, p 971 (2019)
Hemorrhagic hereditary telangiectasia (HHT) type 2 patients have increased activation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway in telangiectasia. The main objective is to evaluate the activation of the PI3K pathway in cutaneous t
Externí odkaz:
https://doaj.org/article/ccc6b7bfe3f042af947a7d253d8b3e32
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Scientific community have gained lots of new insights in the genetic and biochemical background of different conditions, rare diseases included, settling the basis for preclinical models that are helping to identify new biomarkers and therapeutic tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c71bd6465d7244ff175ad9658243d5
https://doi.org/10.1016/j.ejim.2021.09.003
https://doi.org/10.1016/j.ejim.2021.09.003
Publikováno v:
Medicina Clínica. 157:483-488
The overgrowth syndromes related to phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) are grouped under the concept of PROS (PIK3CA-related overgrowth spectrum). It is a heterogeneous group of diseases, considered a rare disease (ORPHA: 530313),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b00c77e7fdff8af84569b22921b1605
https://doi.org/10.1016/j.medcli.2021.03.036
https://doi.org/10.1016/j.medcli.2021.03.036
Publikováno v:
REC: CardioClinics. 57:141-143
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b453ec8c4616ffa619cb2d95a0e2a17
https://doi.org/10.1016/j.rccl.2020.05.003
https://doi.org/10.1016/j.rccl.2020.05.003